Magician Harry Houdini patented a "Diver's Suit" enabling the wearer to "quickly divest himself of the suit while being submerged and to safely escape and reach the surface of the water."
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8114874 | Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use. In particular, the compounds include embodiments in ... | 02/14/2012 |
| 8106191 | Synthetic multimerizing agents New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M-L-Q where M is a synthetic ligand for an FKBP protein. ... | 01/31/2012 |
| 8058426 | Phosphorus-containing compounds and uses thereof This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA- in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may be —V—, â... | 11/15/2011 |
| 7709020 | Implantable device comprising phosphorus-containing macrolides This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA- in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may be —V—, â... | 05/04/2010 |
| 7432277 | Phosphorus-containing macrocycles This invention concerns a new family of phosphorus-containing macrocycles containing various phosphonate- and phosphonate-containing moieties. ... | 10/07/2008 |
| 7238679 | Heterocycles and uses thereof Compounds of the following formula are disclosed: wherein RB is a substituted or unsubstituted aryl or heteroaryl moiety; at least one of RU and RL is a phosphorus-containing moie... | 07/03/2007 |
| 7186826 | Phosphorus-containing compounds and uses thereof This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA— in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may... | 03/06/2007 |
| 7115589 | Purine derivatives This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use. In these compounds, R | 10/03/2006 |
| 7091213 | Phosphorus-containing compounds and uses thereof This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA- in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may b... | 08/15/2006 |
| 7019139 | Quinolinones and uses thereof The invention relates to compounds of the general formula (and pharmaceutically acceptable derivatives thereof): in which RA, RB, RC, RD, R5, R7, R9... | 03/28/2006 |
| 7009054 | Quinolines and uses thereof This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use. ... | 03/07/2006 |
| 6693189 | Materials and method for treating or preventing pathogenic fungal infection This invention concerns derivatives of rapamycin and their antifungal uses. Also disclosed are materials and methods relevant to the identification of non-immunosuppressive anti-fungal rapamycin derivatives. Use of compounds, among others, of the formula ... | 02/17/2004 |
| 6649595 | Regulation of biological events using novel compounds Materials and methods are disclosed for regulation of biological events such as target gene transcription and growth, proliferation or differentiation of engineered cells.... | 11/18/2003 |
| 6576766 | Signal transduction inhibitors, compositions containing them This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediate by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to p... | 06/10/2003 |
| 6573295 | Bicyclic signal transduction inhibitors, compositions containing them & uses thereof This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to ... | 06/03/2003 |
| 6566073 | Materials and methods involving conditional retention domains Materials and methods involving conditional retention domains (CRDs) are disclosed. Also disclosed are fusion proteins containing CRDs and cells expressing such fusion proteins. In addition, the invention provides novel methods for producing target protei... | 05/20/2003 |
| 6506379 | Intramuscular delivery of recombinant AAV This invention concerns new configurations for biological switches and provides new methods and materials useful for regulating biological events in animal cells. The invention involves recombinant DNA constructs comprising DNA sequences derived from sequ... | 01/14/2003 |
| 6482852 | Bicyclic signal transduction inhibitors, compositions containing them & uses thereof This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to ... | 11/19/2002 |
| 6479653 | Compositions and method for regulation of transcription The present invention relates to novel fusion proteins which activate transcription, to nucleic acid constructs encoding the proteins and their use in the genetic engineering of cells.... | 11/12/2002 |
| 6306649 | Heterologous transcription factors This invention provides novel materials and methods involving the heterologous expression of transcription factors which are useful for effecting transcription of target genes in genetically engineered cells or organisms containing them. Target gene const... | 10/23/2001 |
| 6303319 | Cell based assay for identifying sh2-domain-specific signal transducer antagonist The present invention provides methods and compositions for identifying inhibitors of the interaction between phosphopeptide binding pairs, i.e., a protein domain having at least one phosphopeptide binding domain and the phosphorylated ligands that bind t... | 10/16/2001 |
| 6258823 | Materials and method for treating or preventing pathogenic fungal infection This invention concerns derivatives of rapamycin and their antifungal uses. Also disclosed are materials and methods relevant to the identification of non-immunosuppressive antifungal rapamycin derivatives.... | 07/10/2001 |
| 6207397 | In vitro fluorescence polarization assay An in vitro assay method permits the identification of a test substance which inhibits the mutual association of two molecules. The method includes the steps of providing two components capable of mutual association, one of said components bearing a coval... | 03/27/2001 |
| 6187757 | Regulation of biological events using novel compounds Materials and methods are disclosed for regulation of biological events such as target gene transcription and growth, proliferation or differentiation of engineered cells.... | 02/13/2001 |
| 5939528 | Crystalline FRAP complex The invention relates to the human protein FRAP, and in particular to the FKBP12-rapamycin binding domain thereof and to the ternary complex formed by the FRB domain, rapamycin and FKBP12. A new crystalline composition comprising the ternary complex, coor... | 08/17/1999 |
| 5710129 | Inhibitors of SH2-mediated processes This invention relates to compounds of formula: ##STR1## and pharmaceutically acceptable salts thereof, where A is H, R1, --CO--R1 or --CO--OR1 where R1 is a substituted or unsubstituted alkyl, heteroalkyl,... | 01/20/1998 |
| 4835260 | Erythropoietin composition A new improved glycoprotein having erythropoietin-type activity is disclosed. The substrate is characterized by amino acid sequence substantially identical to the amino acid sequence of native human erythropoietin wherein the methionine-54 is replaced wit... | 05/30/1989 |
| 4677195 | Method for the purification of erythropoietin and erythropoietin compositions A method for purifying erythropoietin is described. The method comprises treating partially purifying erythropoietin by reverse phase high performance liquid chromatography to obtain homogeneous erythropoietin having a molecular weight of about 34,000 dal... | 06/30/1987 |